{"id":10908,"date":"2023-05-25T14:47:16","date_gmt":"2023-05-25T18:47:16","guid":{"rendered":"https:\/\/blog.lawyer.com\/?p=10908"},"modified":"2023-05-25T14:47:16","modified_gmt":"2023-05-25T18:47:16","slug":"barking-for-alternatives","status":"publish","type":"post","link":"https:\/\/blog.lawyer.com\/index.php\/barking-for-alternatives\/","title":{"rendered":"Barking for Alternatives"},"content":{"rendered":"<figure id=\"attachment_10909\" aria-describedby=\"caption-attachment-10909\" style=\"width: 300px\" class=\"wp-caption alignright\"><a href=\"https:\/\/blog.lawyer.com\/wp-content\/uploads\/2023\/05\/andrew-s-ouo1hbizWwo-unsplash.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-10909\" src=\"https:\/\/blog.lawyer.com\/wp-content\/uploads\/2023\/05\/andrew-s-ouo1hbizWwo-unsplash-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/blog.lawyer.com\/wp-content\/uploads\/2023\/05\/andrew-s-ouo1hbizWwo-unsplash-300x200.jpg 300w, https:\/\/blog.lawyer.com\/wp-content\/uploads\/2023\/05\/andrew-s-ouo1hbizWwo-unsplash-768x512.jpg 768w, https:\/\/blog.lawyer.com\/wp-content\/uploads\/2023\/05\/andrew-s-ouo1hbizWwo-unsplash-1024x683.jpg 1024w, https:\/\/blog.lawyer.com\/wp-content\/uploads\/2023\/05\/andrew-s-ouo1hbizWwo-unsplash-624x416.jpg 624w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><figcaption id=\"caption-attachment-10909\" class=\"wp-caption-text\">Generic is not necessarily basic<\/figcaption><\/figure>\n<p>Pet owners may pause (or paws) to consider the brand of flea-and-tick medications that they administer to their dogs or cats.\u00a0 In a recent consumer protection-related lawsuit, exclusivity contracts are allegedly to blame for the lack of variety in widespread drug products available to pet owners.\u00a0 According to the claim, if given the fair opportunity to purchase generic options, consumers of Advantage II and K9 Advantix II topical flea-and-tick treatments could have saved a lot of money.\u00a0 As the patent guidelines diminished within the appropriate timeframe, generic brands became available to the market about six years ago.<!--more--><\/p>\n<p>Some of the big-name stores and marketplaces, such as Petco, PetSmart, Chewy.com, and PetMed Express do not carry or offer the generic brands for purchase, and instead, limit their consumers to specific varieties that have increased the customers\u2019 overall <a href=\"https:\/\/www.usatoday.com\/story\/news\/investigations\/2023\/05\/18\/k9-advantix-flea-tick-medicine-generic-bayer-tevra\/70220325007\/\">spending <\/a>by hundreds of dollars.\u00a0 Generic brand companies allege that this design is not by accident and is actually a ploy to eliminate the competition.\u00a0 Tevra Brands is one company that is making this claim and is accusing Bayer Animal Health of employing such monopoly-defined tactics.\u00a0 Tevra is alleging that Bayer is intentionally preventing consumers from locating a favorable deal where they are most likely to shop for their sought-after flea-and-tick protection products.<\/p>\n<p>One company that does sell the generic options is Amazon, which markets Tevra medications for $30, compared to the name brand price of $64 sold on Chewy.com.\u00a0 While the medications are comparable, the prices are vastly different.\u00a0 The reasoning for why this alleged monopoly has gone on for so long is the restriction surrounding insurance.\u00a0 For example, the health insurance that covers people requires generic, low-price alternatives.\u00a0 Pet insurance, however, is not as prevalent as human health insurance, which leaves the chance for greater manipulation of the market.\u00a0 Specifically, exclusivity agreements between top pet drug manufacturers and their vendors prevent certain stores or online retailers from selling competing medications or treatments.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pet owners may pause (or paws) to consider the brand of flea-and-tick medications that they administer to their dogs or cats.\u00a0 In a recent consumer protection-related lawsuit, exclusivity contracts are&#8230;<\/p>\n","protected":false},"author":230,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_s2mail":"yes","footnotes":""},"categories":[548],"tags":[2844,396,2524,236,2727],"class_list":["post-10908","post","type-post","status-publish","format-standard","hentry","category-lawsuits","tag-antitrust-laws","tag-business-2","tag-competition","tag-consumer","tag-monopoly"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/blog.lawyer.com\/index.php\/wp-json\/wp\/v2\/posts\/10908","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.lawyer.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.lawyer.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.lawyer.com\/index.php\/wp-json\/wp\/v2\/users\/230"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.lawyer.com\/index.php\/wp-json\/wp\/v2\/comments?post=10908"}],"version-history":[{"count":4,"href":"https:\/\/blog.lawyer.com\/index.php\/wp-json\/wp\/v2\/posts\/10908\/revisions"}],"predecessor-version":[{"id":10913,"href":"https:\/\/blog.lawyer.com\/index.php\/wp-json\/wp\/v2\/posts\/10908\/revisions\/10913"}],"wp:attachment":[{"href":"https:\/\/blog.lawyer.com\/index.php\/wp-json\/wp\/v2\/media?parent=10908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.lawyer.com\/index.php\/wp-json\/wp\/v2\/categories?post=10908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.lawyer.com\/index.php\/wp-json\/wp\/v2\/tags?post=10908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}